V
Victoria Alexandra Steadman
Researcher at NovoBiotic Pharmaceuticals
Publications - 12
Citations - 2154
Victoria Alexandra Steadman is an academic researcher from NovoBiotic Pharmaceuticals. The author has contributed to research in topics: Cyclophilin & Antibiotic resistance. The author has an hindex of 6, co-authored 11 publications receiving 1849 citations.
Papers
More filters
Journal ArticleDOI
A new antibiotic kills pathogens without detectable resistance
Losee Lucy Ling,Tanja Schneider,Aaron J. Peoples,Amy Spoering,Ina Engels,Brian P. Conlon,A. Mueller,Till F. Schäberle,Dallas Hughes,Slava S. Epstein,M. Jones,Linos Lazarides,Victoria Alexandra Steadman,Cohen Dr,Cintia R. Felix,Fetterman Ka,William Millett,Anthony Nitti,Ashley Zullo,Chao Chen,Kim Lewis +20 more
TL;DR: The properties of this compound suggest a path towards developing antibiotics that are likely to avoid development of resistance, as well as several methods to grow uncultured organisms by cultivation in situ or by using specific growth factors.
Patent
Macrocyclic inhibitors of flaviviridae viruses
Caroline Aciro,Chiva Jean Yves,David Kenneth Dean,Adrian John Highton,Petr Jansa,Andrew John Keats,Linos Lazarides,Richard L. Mackman,Karine G. Poullennec,Adam J. Schrier,Dustin Siegel,Victoria Alexandra Steadman,Gregory M. Watt +12 more
TL;DR: In this article, compounds of Formula I: and pharmaceutically acceptable salts and esters thereof are provided for the treatment of virus infections, particularly hepatitis C infections. But none of these compounds are suitable for the use in medical applications.
Journal ArticleDOI
Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle.
Richard L. Mackman,Victoria Alexandra Steadman,David Kenneth Dean,Petr Jansa,Karine G. Poullennec,Todd C. Appleby,Carol Austin,Caroline A. Blakemore,Ruby Cai,Carina E. Cannizzaro,Gregory Chin,Jean-Yves Christophe Chiva,Neil Andrew Dunbar,Hans G. Fliri,Adrian John Highton,Hui Hon Chung,Mingzhe Ji,Haolun Jin,Karki Kapil Kumar,Andrew John Keats,Linos Lazarides,Yu-Jen Lee,Albert Liclican,Mish Michael R,Bernard P. Murray,Simon B. Pettit,Peter Pyun,Sangi Michael,Rex Santos,Jonathan Sanvoisin,Uli Schmitz,Adam J. Schrier,Dustin Siegel,David Sperandio,George Stepan,Yang Tian,Gregory M. Watt,Hai Yang,Brian E. Schultz +38 more
TL;DR: The synthetic accessibility and properties of cyclophilin inhibitor support its potential as an anti-HCV agent and for interrogating the role of Cyp inhibition in a variety of diseases.
Journal ArticleDOI
Erratum: A new antibiotic kills pathogens without detectable resistance
Losee L Ling,Tanja Schneider,Aaron J. Peoples,Amy Spoering,Ina Engels,Brian P. Conlon,Anna Mueller,Till F. Schäberle,Dallas Hughes,Slava S. Epstein,M. Jones,Linos Lazarides,Victoria Alexandra Steadman,Douglas R. Cohen,Cintia R. Felix,K. Ashley Fetterman,William Millett,Anthony Nitti,Ashley Zullo,Chao Chen,Kim Lewis +20 more
TL;DR: This corrects the article to show that the Higgs boson genome is a “spatially aggregated “vessel” rather than an “ aggregating “ nucleus”, which indicates that theorems related to “consolidation” and “ghosting” are more likely to occur.
Journal ArticleDOI
Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A
Victoria Alexandra Steadman,Simon B. Pettit,Karine G. Poullennec,Linos Lazarides,Andrew John Keats,David Kenneth Dean,Steven J. Stanway,Carol Austin,Jonathan Sanvoisin,Gregory M. Watt,Hans G. Fliri,Albert Liclican,Debi Jin,Melanie H. Wong,Stephanie A. Leavitt,Yu-Jen Lee,Yang Tian,Christian R. Frey,Todd C. Appleby,Uli Schmitz,Petr Jansa,Richard L. Mackman,Brian E. Schultz +22 more
TL;DR: Replacing the C18-C21 diene unit of sanglifehrin with a styryl group led to potent compounds that displayed a novel binding mode in which the styrene moiety engaged in a π-stacking interaction with Arg55 of cyclophilin A (Cyp A), and the m-Tyr residue was displaced into solvent.